Hiroko Oshima

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Dna Damage Response

Protein Protein

Top Venues

The Journal of pathology

Cancer research

Nature immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Dong Wang, Mizuho Nakayama, Chang Pyo Hong, Hiroko Oshima, Masanobu Oshima
Gain-of-function p53 mutation acts as a genetic switch for TGF-β signaling-induced epithelial-to-mesenchymal transition in intestinal tumors. Cancer research (2023)
Daisuke Yamamoto, Hiroko Oshima, Dong Wang, Haruna Takeda, Kenji Kita, Xuelian Lei, Mizuho Nakayama, Kazuhiro Murakami, Takashi Ohama, Hirofumi Takemura, Mutsumi Toyota, Hiromu Suzuki, Noriyuki Inaki, Masanobu Oshima
Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer. The Journal of pathology 257 (1) (2022)
Sho Hangai, Takeshi Kawamura, Yoshitaka Kimura, Ching-Yun Chang, Sana Hibino, Daisuke Yamamoto, Yousuke Nakai, Ryosuke Tateishi, Masanobu Oshima, Hiroko Oshima, Tatsuhiko Kodama, Kyoji Moriya, Kazuhiko Koike, Hideyuki Yanai, Tadatsugu Taniguchi
Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells. Nature immunology 22 (8) (2021)
Toshikatsu Tsuji, Yusuke Maeda, Kenji Kita, Kazuhiro Murakami, Hideyuki Saya, Hirofumi Takemura, Noriyuki Inaki, Masanobu Oshima, Hiroko Oshima
FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells. Oncogene 40 (17) (2021)